Scientific Advisory Board

Jim Vaught
Dr. Jim Vaught
Editor-in-Chief of Biopreservation and Biobanking

Dr. Jim Vaught spent 14 years at the U.S. National Cancer Institute (NCI), most recently as the Chief of the Biorepositories and Biospecimen Research Branch (BBRB) in the Cancer Diagnosis Program. He has been working in the field of biorepository and biospecimen science for over 20 years. In 1999, he was one of the founding members of the International Society for Biological & Environmental Repositories (ISBER). He serves on a number of biobank advisory groups including the Telethon-Italy Genetic Biobank Network; the Biobanques Network (France) Scientific Board; and the Provia Labs (Boston) Advisory Board. He is a member of the Board of Directors of the National Disease Research Interchange. He is Senior Biobank Advisor to the Shanghai Clinical Research Center. In addition to ISBER, Dr. Vaught is a member of the American Association for Cancer Research (AACR), the American Society for Pharmacology and Experimental Therapeutics, the European Society for Biopreservation & Biobanking, the American Association of Blood Banks, and the American Association for Clinical Chemistry. He is the author of over 70 peer-reviewed articles and book chapters. From 2006 to 2012 he was Senior Editor for Biospecimens and Biorepositories for the AACR journal Cancer Epidemiology, Biomarkers and Prevention. In 2012 he became Editor-in-Chief of Biopreservation and Biobanking, the official journal of ISBER. He is currently a Senior Research Fellow at the International Prevention Research Institute (Lyon), and a consultant for a number of international biobanking activities. Dr. Vaught is the President of ISBER for 2015-2016.

Carolyn Compton
Dr. Carolyn Compton
Professor of Life Sciences, Arizona State University

Carolyn Compton, M.D., Ph.D., is an academic pathologist specializing in gastrointestinal disease and is board certified in both anatomic and clinical pathology. She is a Professor of Life Sciences at Arizona State University and a Professor of Laboratory Medicine and Pathology at the Mayo Clinic School of Medicine. She is an adjunct Professor of Pathology at the Johns Hopkins Medical School and the University of Arizona School of Medicine. She is the Chief Medical Officer of the National Biomarkers Development Alliance, a member of the BioDesign Institute, and the Chief Medical Officer of the Complex Adaptive Systems Institute. She is a former Professor of Pathology at Harvard Medical School, Chief of Gastrointestinal Pathology at Massachusetts General Hospital and Pathologist-in-Chief of the Boston Shriners Children’s Hospital. More recently she has served as the CEO and President of the Critical Path Institute, the Director of the Office of Biorepositories and Biospecimen Research and the Director of the Innovative Molecular Analysis Technologies program at the National Cancer Institute, and the Strathcona Professor and Chair of the Department of Pathology at McGill University and Pathologist-in-Chief of the McGill University Health Center. She is a past Chair of the Cancer Committee of the College of American Pathologists and the immediate past Chair of the American Joint Committee on Cancer (AJCC). Currently, she is the Chair of the Precision Medicine Core of the AJCC and the Chair of the Specimen Standards for Precision Medicine Project of the College of American Pathologists. Her research interests focus on colorectal cancer, medical prediction, biospecimen and biobanking science, and biomarker development. She has authored more than 350 scientific manuscripts, review articles, books, and chapters.

James Robb
Dr. James Robb
Consulting Pathologist, Boca Raton

Dr. Robb is board certified in anatomic pathology, clinical pathology, cytopathology, and dermatopathology. He is a consulting pathologist to the National Cancer Institute (NCI) via the Nationwide Children’s Hospital, Columbus, OH, Strategic Visions, Inc. Biomatrica, Inc. and a member of the CAP's Council on Scientific Affairs (CSA), the Council on Education, the Personalized Health Care Committee, the SNOMED-CT Editorial Board, the Ad Hoc Committee on Pathology Report Standardization, and the CSA Working Group on Informed Consent for Biospecimens. He has been Senior Surgeon at NIH; Professor of Pathology at University California at San Diego; staff pathologist and director of cytopathology and molecular pathology at Scripps Clinic, La Jolla, California; Director of Anatomic and Molecular Pathology, Cedars MC, Miami, Florida; Medical Director of the HCA East Florida Division’s Integrated Regional Laboratories system, and College of American Pathologists governor. He has served as the National Cancer Institute’s (NCI at NIH) pathology lead in the NCI Community Cancer Center Program (NCCCP) and the NCI’s US-Latin America Cancer Research Network (US-LA CRN), as well as part of the development team for the NCI Cancer Human Biobank program (CaHUB).

Elena Salvaterra
Dr. Elena Salvaterra
Senior Consultant at Icmed

Elena Salvaterra is a Jurist Doctor and PhD in Philosophy of Law with an international expertise in ethics in biobanking. She has worked for several years at the Department of Philosophy of Law at the University of Milan (Italy). There, she conducted research on ethical and regulatory aspects related to health care decisions, end of life decisions, consent and ethical aspects in pharmacology. Then she worked at the Biological Research Center of the Polyclinic University Hospital of Milan, where she coordinated empirical research on ethical and regulatory aspects of human biobanks, including therapeutic and research collections. Since 2009, she has been collaborating in projects concerning ethical aspects associated with neurological disorders. She is the author of several peer reviewed papers and the co-founder of ESBB (European, Middle Eastern & African Society for Biopreservation & Biobanking). She is an invited speaker at several national and international conferences on biobanking. Elena has received her degree in law from the University of Como, Italy and Ph.D. Philosophy of Law, Bioethics and Law of Science from the University of Milano.

Stephen Goldman
Mr. Stephen Goldman
Laboratory Director at PhytaTechSM

Stephen is an analytical chemist and has worked extensively in both industrial and academic laboratories. He has over 10 years of experience in pharmaceutical, nutraceutical, and biotechnology industries. He currently serves as Laboratory Director at a State of Colorado certified Cannabis testing facility, PhytaTechSM. He is the founder of a scientific consulting firm located in Denver, Colorado. He has published extensively in the fields of biological and analytical chemistry. He is a member of the American Institute of Chemical Engineers, American Association of Pharmaceutical Scientists, International Cannabinoid Research Society, and the American Chemical Society. Stephen graduated in Chemical and Biochemical Engineering from the University of Iowa and earned his MS in Pharmaceutical Chemistry with Honors from the University of Kansas.

Susan Audino
Dr. Susan Audino
Cannabis Advisory Panel and Chair, Cannabis Working Group at AOAC International

Susan Audino obtained her PhD in Chemistry with an analytical chemistry major, physical and biochemistry minor areas. She currently owns and operates a consulting firm to service chemical and biological laboratories, is an A2LA Lead Assessor and Instructor, is a Board Member for the Center for Research on Environmental Medicine in Maryland, and serves on several expert advisory panels for the cannabis industry. Susan has been studying the chemistry and applications of cannabinoids and provides scientific and technical guidance to cannabis dispensaries, testing laboratories, and medical personnel. Dr. Audino’s interest most directly involves cannabis consumer safety and protection, and promotes active research towards the development of Official Test methods specifically for the cannabis industry, and to advocate appropriate clinical research. In addition to serving on Expert Review Panels, she is also chairing the first Cannabis Advisory Panel and working group with AOAC International, is a member of the Executive Committee of the ASTM Cannabis Section, and has consulted to numerous cannabis laboratories and state regulatory bodies.

© All Rights Reserved.